Evidence map›Paper›PMID 32283763›Full record

ArticleMolecules (Basel, Switzerland)2020

Enhancing the Membranolytic Activity of

Emmanuel Colson, Philippe Savarino, Emily J S Claereboudt, Gustavo Cabrera-Barjas, Magali Deleu, Laurence Lins, Igor Eeckhaut, Patrick Flammang, Pascal Gerbaux

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Impact of the Hydrolysis and Methanolysis of BidesmosidicMolecules (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Emmanuel ColsonOrganic Synthesis and Mass Spectrometry Laboratory (S²MOs), University of Mons-UMONS, 23 Place du Parc, 7000 Mons; Belgium.
Philippe SavarinoOrganic Synthesis and Mass Spectrometry Laboratory (S²MOs), University of Mons-UMONS, 23 Place du Parc, 7000 Mons; Belgium.
Emily J S ClaereboudtBiology of Marine Organisms and Biomimetics Unit (BOMB), University of Mons-UMONS, 23 Place du Parc, 7000 Mons, Belgium.
Gustavo Cabrera-BarjasUnidad de Desarrollo Tecnológico (UDT), Universidad de Concepción, Av. Cordillera 2634, Parque Industrial Coronel, P.O. Box 4051 mail 3, Coronel 4191996, Región del BíoBío, Chile.
Magali DeleuLaboratory of Molecular Biophysics at Interfaces, TERRA Research Center, Gembloux Agro-Bio Tech, University of Liege, 5030 Gembloux, Belgium.ORCID 0000-0001-8255-2965
Laurence LinsLaboratory of Molecular Biophysics at Interfaces, TERRA Research Center, Gembloux Agro-Bio Tech, University of Liege, 5030 Gembloux, Belgium.
Igor EeckhautBiology of Marine Organisms and Biomimetics Unit (BOMB), University of Mons-UMONS, 23 Place du Parc, 7000 Mons, Belgium.
Patrick FlammangBiology of Marine Organisms and Biomimetics Unit (BOMB), University of Mons-UMONS, 23 Place du Parc, 7000 Mons, Belgium.
Pascal GerbauxOrganic Synthesis and Mass Spectrometry Laboratory (S²MOs), University of Mons-UMONS, 23 Place du Parc, 7000 Mons; Belgium.ORCID 0000-0001-5114-4352
University of Mons · BEUniversity of Liège · BEUniversity of Concepción · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Saponins are plant secondary metabolites. There are associated with defensive roles due to their cytotoxicity and are active against microorganisms. Saponins are frequently targeted to develop efficient drugs. Plant biomass containing saponins deserves sustained interest to develop high-added value applications. A key issue when considering the use of saponins for human healthcare is their toxicity that must be modulated before envisaging any biomedical application. This can only go through understanding the saponin-membrane interactions. Quinoa is abundantly consumed worldwide, but the quinoa husk is discarded due to its astringent taste associated with its saponin content. Here, we focus on the saponins of the quinoa husk extract (QE). We qualitatively and quantitively characterized the QE saponins using mass spectrometry. They are bidesmosidic molecules, with two oligosaccharidic chains appended on the aglycone with two different linkages; a glycosidic bond and an ester function. The latter can be hydrolyzed to prepare monodesmosidic molecules. The microwave-assisted hydrolysis reaction was optimized to produce monodesmosidic saponins. The membranolytic activity of the saponins was assayed based on their hemolytic activity that was shown to be drastically increased upon hydrolysis. In silico investigations confirmed that the monodesmosidic saponins interact preferentially with a model phospholipid bilayer, explaining the measured increased hemolytic activity.

Indexed as

MicrowavesChenopodium quinoaChromatography, LiquidHydrolysisMass SpectrometryMolecular StructurePlant ExtractsSaponinsStructure-Activity RelationshipTemperaturePlant ExtractsSaponinsmass spectrometrymicrowave heatingquinoasaponinstructure activity relationship

Identifiers

PMID32283763
PMCPMC7181122
OpenAlexW3015504191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.